Revenue distribution by industry:

• Pharmaceutical distribution: approx. 85%
• Medical products and services: approx. 15%

TOP 3 markets:

1. USA: approx. 75%
2. Canada: approx. 10%
3. Europe: approx. 8%

Cardinal Health, Inc. generates the majority of its revenue from pharmaceutical distribution, which is the company's core competency. The U.S. market is the main revenue driver, followed by Canada and Europe. These markets are crucial for the company as they have a high demand for pharmaceutical products and medical services. The strong presence in the USA can be attributed to the extensive network and long-standing relationships with major healthcare facilities.

Production Sites: USA, Europe, Asia

Cardinal Health, Inc. is a globally active healthcare services and logistics company. The company produces and distributes a variety of medical and pharmaceutical products. Cardinal Health's production facilities are mainly located in the USA, Europe, and Asia. This geographical distribution enables the company to efficiently meet the needs of different markets and optimize supply chains.

Through strategic partnerships and acquisitions, Cardinal Health has continuously expanded its production capacities and sites to ensure supply security and optimize production costs.

Revenue Growth: Estimated 4-6% annually (2025) Profit Growth: Estimated 5-7% annually (2025)

Cardinal Health, Inc. pursues a growth strategy based on several pillars. Firstly, the company focuses on optimizing its supply chain and improving efficiency in its operational processes. This is intended to be achieved through investments in technology and automation.

Secondly, Cardinal Health is expanding its product portfolio, especially in the area of specialized healthcare solutions. This includes both organic growth and strategic acquisitions to enter new markets and expand its existing offerings.

Furthermore, the company places great emphasis on strengthening its customer relationships and enhancing the customer experience. This is achieved through tailored solutions and services that meet the specific needs of customers.

Overall, Cardinal Health aims to solidify and expand its market position through innovation, efficiency improvements, and increased customer orientation.

Main raw materials: Medical products, pharmaceutical products, medical devices

Countries of origin: China, Germany, India, Mexico

Cardinal Health, Inc. is a leading company in the healthcare sector and distributes a variety of medical and pharmaceutical products. The company mainly imports medical devices and pharmaceutical products.

China and India are significant suppliers of pharmaceutical raw materials and medical devices. Germany supplies specialized medical devices and technologies. Mexico is also an important partner, especially for the manufacturing and export of medical products to the USA.

These international partnerships are crucial for maintaining supply chains and ensuring product availability in the US market.

Market share: 20% (estimated, 2025) Gross margin: 4.5% (2024) Return on Equity (ROE): 25% (2024)

Cardinal Health, Inc. has a significant competitive advantage in the healthcare industry, especially in the medical care and distribution sector. With an estimated market share of 20%, the company is among the leading players in its sector, indicating a strong market presence and customer loyalty.

The gross margin of 4.5% shows that the company is able to manage its costs efficiently, although margins in the distribution industry are typically low. This suggests operational efficiency and economies of scale.

A return on equity of 25% in 2024 underscores Cardinal Health's ability to achieve high returns on the capital invested, indicating effective resource utilization and strong financial performance. Taken together, these metrics suggest that Cardinal Health possesses a solid competitive advantage supported by its size, efficiency, and market position.

Institutional Investor Share: approx. 90% (estimated for 2025 based on historical data)

Insider Buys/Sells: No significant changes in the last year (estimated)

Cardinal Health, Inc. has traditionally had a high proportion of institutional investors, indicating the confidence of large investment funds and institutional investors in the company's stability and growth potential.

In recent years, there have been no significant insider transactions, indicating that management has confidence in the current corporate strategy and development. This is often a positive signal for investors as it indicates stable corporate leadership.

Market share of Cardinal Health, Inc.: 15% (estimated for 2025)

Main competitors and their market shares:

1. McKesson Corporation: 20%
2. AmerisourceBergen Corporation: 18%
3. Cardinal Health, Inc.: 15%
4. Walgreens Boots Alliance: 10%
5. Cigna Corporation: 8%
6. CVS Health: 7%
7. Henry Schein: 5%
8. Medline Industries: 4%
9. Owens & Minor: 3%
10. Patterson Companies: 2%

Cardinal Health, Inc. is one of the leading players in the healthcare and pharmaceutical distribution industry. The market share of 15% positions the company as one of the top 3 players in the sector. Cardinal Health's moat lies in its extensive supply chain, long-standing experience, and established network of healthcare providers.

Compared to its competitors, McKesson has the largest market share and a strong moat due to its comprehensive logistics and technology integration. AmerisourceBergen benefits from strategic partnerships and a global presence, which also provide a significant advantage.

Cardinal Health has a solid moat, but they need to continuously invest in technology and efficiency to keep up with the leading competitors. The competition is intense, and differentiation often occurs through service quality, efficiency, and innovation capability.

Revenue growth: 10% (2024) Profit growth: 8% (2024) Dividend yield: 2.5% (2024)

Cardinal Health, Inc. recorded a revenue growth of 10% in 2024, attributed to strong demand in the medical care and pharmaceutical distribution sectors. The 8% profit growth indicates that the company is able to maintain its margins despite a competitive market.

The dividend yield of 2.5% is attractive to investors seeking stable returns. Cardinal Health has a long history of dividend payments, indicating a solid financial foundation.

Overall, the financial performance and dividend policy suggest that Cardinal Health could be a stable investment for investors interested in long-term growth and regular returns. The company's market position and the continuous demand for healthcare services support this assessment.

Dividend yield: 2.5% (estimated for 2025)
Dividend history: Continuous payout over the last 10 years

Cardinal Health, Inc. regularly pays a dividend to its shareholders. The dividend yield is currently around 2.5%, which can be considered moderate compared to other companies in the healthcare sector.

Over the past ten years, the company has consistently distributed dividends, indicating a reliable dividend policy. This suggests that Cardinal Health has a stable financial foundation and is committed to providing shareholders with consistent value.

The reliability of the payout is supported by the company's solid financial performance and strategic positioning in the healthcare sector. Analysts expect that Cardinal Health will continue to be able to pay dividends in the coming years, provided that no significant negative economic developments occur.